GLP-1 & GIP Drugs Raise Gastric Volume Risk in Endoscopy
GLP-1 Agonists and Upper Endoscopy: New Study Warns of Increased Gastric Volume Risks Medical professionals are raising a red flag for millions of patients using popular weight-loss and diabetes medications. A recent randomized clinical trial has revealed a concerning link between the continued use of GLP-1 and GLP-1/GIP receptor agonists and an increased risk of … Read more